CoChat

AS1411-conjugated gold nanospheres and their potential for breast cancer therapy

Open access
Malik, Mohammad T., O’Toole, Martin G., Casson, Lavona K., Thomas, Shelia D., Bardi, Gina T., Reyes-Reyes, Elsa Merit, Ng, Chin K., Kang, Kyung A., Bates, Paula J. · 2015 · Oncotarget
Cited by 116

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

// Mohammad T. Malik 1, 5 , Martin G. O’Toole 2 , Lavona K. Casson 1, 5 , Shelia D. Thomas 1, 5 , Gina T. Bardi 1, 5 , Elsa Merit Reyes-Reyes 1, 5 , Chin K. Ng 3 , Kyung A. Kang 4 , Paula J. Bates 1, 5 1 Departments of Medicine, University of Louisville, Louisville, Kentucky, USA 2 Departments of Bioengineering, University of Louisville, Louisville, Kentucky, USA 3 Departments of Radiology, University of Louisville, Louisville, Kentucky, USA 4 Departments of Chemical Engineering, University of Louisville, Louisville, Kentucky, USA 5 Departments of the Molecular Targets Group of the James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky, USA Correspondence to: Mohammad T. Malik, e-mail: tariq.malik@louisville.edu Paula J. Bates, e-mail: paula.bates@louisville.edu Keywords: targeted therapy, nanomedicine, triple negative breast cancer, G-quadruplex, nanoparticles Received: May 11, 2015 Accepted: May 22, 2015 Published: June 03, 2015 ABSTRACT AS1411 is a quadruplex-forming DNA oligonucleotide that functions as an aptamer to target nucleolin, a protein present on the surface of cancer cells. Clinical trials of AS1411 have indicated it is well tolerated with evidence of therapeutic activity, but improved pharmacology and potency may be required for optimal efficacy. In this report, we describe how conjugating AS1411 to 5 nm gold nanospheres influences its activities in vitro and in vivo . We find that the AS1411-linked gold nanospheres (AS1411-GNS) are stable in aqueous and serum-containing solutions. Compared to unconjugated AS1411 or GNS linked to control oligonucleotides, AS1411-GNS have superior cellular uptake and markedly increased antiproliferative/cytotoxic effects. Similar to AS1411, AS1411-GNS show selectivity for cancer cells compared to non-malignant cells. In a mouse model of breast cancer, systemic administration of AS1411-GNS could completely inhibit tumor growth with no signs of toxicity. These results suggest AS1411-GNS are promising candidates for clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.4207

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 116

Metadata

Authors
Malik, M. T., O’Toole, M. G., Casson, L. K., Thomas, S. D., Bardi, G. T., Reyes-Reyes, E. M., Ng, C. K., Kang, K. A., & Bates, P. J.
Venue
Oncotarget
Published
2015-06-03
Volume
6
Issue
26
Pages
22270-22281
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1892505945
Cited by
116
References
1
FWCI
4.84
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.